Corient Private Wealth LP purchased a new stake in Cabot Corporation (NYSE:CBT - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 12,554 shares of the specialty chemicals company's stock, valued at approximately $1,140,000.
Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. bought a new stake in Cabot during the 2nd quarter worth $633,302,000. Fuller & Thaler Asset Management Inc. boosted its holdings in Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company's stock valued at $155,315,000 after acquiring an additional 124,613 shares during the last quarter. State Street Corp increased its position in shares of Cabot by 1.0% during the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company's stock worth $134,256,000 after buying an additional 20,021 shares during the period. Dimensional Fund Advisors LP grew its holdings in Cabot by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company's stock worth $131,253,000 after acquiring an additional 79,499 shares during the period. Finally, Bank of America Corp DE increased its holdings in Cabot by 3.9% in the third quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company's stock worth $128,032,000 after purchasing an additional 63,080 shares in the last quarter. Institutional investors own 93.18% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have weighed in on CBT shares. Truist Financial set a $100.00 price target on shares of Cabot in a research note on Wednesday, August 5th. Mizuho boosted their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a report on Thursday, June 25th. JPMorgan Chase & Co. raised their target price on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research report on Friday, August 7th. Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a research report on Friday, August 21st. Finally, UBS Group cut their price target on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $89.00.
Check Out Our Latest Stock Report on CBT
Insider Activity at Cabot
In other news, CEO Sean Keohane sold 134,895 shares of the business's stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer owned 404,134 shares of the company's stock, valued at approximately $34,351,390. The trade was a 25.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold a total of 229,597 shares of company stock valued at $19,646,746 in the last quarter. 3.08% of the stock is currently owned by insiders.
Cabot Price Performance
Shares of NYSE:CBT opened at $81.47 on Friday. The company's fifty day moving average price is $86.67 and its 200-day moving average price is $81.40. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The firm has a market capitalization of $4.21 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 10.66 and a beta of 0.83. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53.
Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities research analysts anticipate that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.
Cabot Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot's dividend payout ratio (DPR) is 53.24%.
About Cabot
(
Free Report)
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
